Note to users. If you're seeing this message, it means that your browser cannot find this page's style/presentation instructions -- or possibly that you are using a browser that does not support current Web standards. Find out more about why this message is appearing, and what you can do to make your experience of our site the best it can be.


Science 5 May 1978:
Vol. 200. no. 4341, pp. 563 - 565
DOI: 10.1126/science.200.4341.563

Articles

(S)-9-(2,3-Dihydroxypropyl)adenine: An Aliphatic Nucleoside Analog with Broad-Spectrum Antiviral Activity

ERIK DE CLERCQ 1, JOHAN DESCAMPS 1, PIERRE DE SOMER 1, and ANTONÍN HOLYacute 2

1 Rega Institute for Medical Research, University of Leuven, B-3000 Leuven, Belgium
2 Institute of Organic Chemistry and Biochemistry, Czechoslovak Academy of Sciences, 166 10 Prague

(S)-9-(2,3-Dihydroxypropyl)adenine, a novel nucleoside analog, the sugar moiety of which is replaced by an aliphatic chain, inhibits the replication in vitro of several DNA and RNA viruses, including vaccinia, herpes simplex (types 1 and 2), measles, and vesicular stomatitis. It is also effective in vivo in reducing the mortality rate of mice inoculated intranasally with vesicular stomatitis virus.

Submitted on January 18, 1978


THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES:
Inhibition of S-Adenosylhomocysteine Hydrolase by Acyclic Sugar Adenosine Analogue D-Eritadenine. CRYSTAL STRUCTURE OF S-ADENOSYLHOMOCYSTEINE HYDROLASE COMPLEXED WITH D-ERITADENINE.
Y. Huang, J. Komoto, Y. Takata, D. R. Powell, T. Gomi, H. Ogawa, M. Fujioka, and F. Takusagawa (2002)
J. Biol. Chem. 277, 7477-7482
   Abstract »    Full Text »    PDF »
Vaccinia Virus Inhibitors as a Paradigm for the Chemotherapy of Poxvirus Infections.
E. De Clercq (2001)
Clin. Microbiol. Rev. 14, 382-397
   Abstract »    Full Text »    PDF »
Molecular Targets for Antiviral Agents.
E. De Clercq (2001)
J. Pharmacol. Exp. Ther. 297, 1-10
   Abstract »    Full Text »



To Advertise     Find Products


Science. ISSN 0036-8075 (print), 1095-9203 (online)